Category: TrialPal

Table of Contents “Utilizing ePROs not only facilitates better data collection but also contributes to improved quality of care and patient safety”. “FIdec achieved over 98% patient adherence using the proper ePRO” ePRO stands for electronic Patient Reported Outcomes. This system allows patients to report their health status, symptoms, and quality of life using digital… Continue reading Electronic Patient-Reported Outcomes in Clinical Trials

Table of Contents When developing new vaccines, patient safety is paramount. Phase I vaccine trials determine safety and efficacy before public release. Data collection is crucial for evaluating the vaccine’s performance.   Electronic Patient Reported Outcomes (ePRO) are valuable tools in ensuring patient safety during Phase I vaccine trials. This article explores the importance of… Continue reading Phase I Vaccine Trials & ePRO: Ensuring Patient Safety  

Artificial intelligence (AI) and machine learning (ML) herald a new era of regulatory operations in clinical trials. These advanced technologies are revolutionizing how companies manage regulatory data, predict outcomes, and ensure compliance, ultimately leading to greater efficiency and accuracy.   From the IQVIA article published on its website on June 10, 2024, we would like… Continue reading 4 Key Benefits of AI & Machine Learning in Clinical Trials

From the ideation of the scientific question, sponsors can consider integrating ePRO tools in protocol designs. Decentralized and hybrid clinical trials can widen the data points and make the most of each trial. Here we share five steps to introduce an ePRO into a protocol: Define the objectives an ePRO tool can address: Identify the… Continue reading How to include an ePRO in your protocol design

What is electronic patient-reported outcomes (ePRO)? ePRO stands for “Electronic Patient-Reported Outcomes.” It is a tool that allows patients to record electronically and submit their health outcomes digitally using devices such as smartphones, tablets, or computers. Electronic patient-reported outcomes (ePRO) is an innovative tool that transforms how data is collected and analyzed in clinical trials. … Continue reading What is ePRO, Electronic Patient-Reported Outcome?

Table of Contents The global eCOA market is poised for significant growth in the coming years. Grand View Research shows the market is expected to reach $20.5 billion by 2028. eCOA (electronic Clinical Outcome Assessment) uses electronic tools and technologies to collect and evaluate patient outcome data in clinical trials and clinical research. It allows… Continue reading Electronic Clinical Outcome Assessment (eCOA): What is and Who Uses it?

Poor patient reporting adherence can prolong the trial duration by increasing the time required to gather complete and accurate data. This can extend the overall cost of the trial while burdening the study team and site, and compromise future submissions.   Patient reporting adherence facilitates the early identification of symptoms and risk factors, prevents dropouts,… Continue reading Adherence Reporting in Vaccine Trials: [+98% Adherence Rates]

Electronic Clinical Outcome Assessments (eCOA) and Electronic Patient Reported Outcomes (ePRO) are two types of electronic data collection methods. While they may seem similar, there are some differences between them that are important to acknowledge.   ePRO involves patients reporting their own health outcomes directly to their healthcare provider or research team. This is usually… Continue reading Differences and similarities between an eCOA and ePRO

ePRO/eCOA Capabilities to better conduct Clinical Studies ePRO/eCOA tools have revolutionized the clinical research industry. The first concept was raised a decade ago, but the idea of integrations between systems or interoperability was far from easy. In the past three years, the industry has experienced a boom of new technology development, broadening the data source… Continue reading Seven ePRO/eCOA Capabilities to Better Conduct Clinical Studies in Latin America